180 related articles for article (PubMed ID: 12773014)
1. Adjuvant therapy of melanoma.
Geskin L; Brown CR; Kirkwood JM
Semin Cutan Med Surg; 2003 Mar; 22(1):55-67. PubMed ID: 12773014
[No Abstract] [Full Text] [Related]
2. Adjuvant therapy for malignant melanoma.
Stoutenburg JP; Schrope B; Kaufman HL
Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant interferon in melanoma - a resurrection?
Middleton MR; Thatcher N
Br J Cancer; 2001 May; 84(9):1141-2. PubMed ID: 11336461
[No Abstract] [Full Text] [Related]
4. The systemic treatment of advanced cutaneous melanoma.
Logan TF
Facial Plast Surg Clin North Am; 2003 Feb; 11(1):75-85. PubMed ID: 15062290
[No Abstract] [Full Text] [Related]
5. The treatment of metastatic melanoma with chemotherapy and biologics.
Atkins MB
Curr Opin Oncol; 1997 Mar; 9(2):205-13. PubMed ID: 9161801
[TBL] [Abstract][Full Text] [Related]
6. What's new in the treatment of cutaneous melanoma?
Olhoffer IH; Bolognia JL
Semin Cutan Med Surg; 1998 Jun; 17(2):96-107. PubMed ID: 9669603
[TBL] [Abstract][Full Text] [Related]
7. How melanoma is treated in real life.
Dummer R; Schadendorf D
Arch Dermatol; 2008 May; 144(5):664-5. PubMed ID: 18490596
[No Abstract] [Full Text] [Related]
8. Adjuvant therapy for cutaneous melanoma.
Nathan FE; Mastrangelo MJ
Semin Oncol; 1995 Dec; 22(6):647-61. PubMed ID: 8539640
[No Abstract] [Full Text] [Related]
9. Systemic therapy for cutaneous melanoma.
Treisman J; Garlie N
Clin Plast Surg; 2010 Jan; 37(1):127-46. PubMed ID: 19914464
[TBL] [Abstract][Full Text] [Related]
10. [Adjuvant interferon treatment of melanoma].
Török L
Magy Onkol; 2003; 47(1):105-7. PubMed ID: 12704462
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant high-dose interferon therapy for high-risk melanoma.
Ready N; Weinstock MA
Arch Dermatol; 2003 Dec; 139(12):1635-7. PubMed ID: 14676083
[No Abstract] [Full Text] [Related]
12. Need for a quantitative meta-analysis of trials of adjuvant interferon in melanoma.
Wheatley K; Ives N; Hancock B; Gore M
J Clin Oncol; 2002 Oct; 20(19):4120-1; author reply 4121-2. PubMed ID: 12351611
[No Abstract] [Full Text] [Related]
13. Adjuvant interferon therapy for melanoma.
Hancock B; Wheatley K; Ives N; Gore M
J Clin Oncol; 2005 Apr; 23(10):2431; author reply 2431-2. PubMed ID: 15800339
[No Abstract] [Full Text] [Related]
14. What can we learn from phase II adjuvant trials in melanoma?
Keilholz U; Suciu S; Eggermont AM
Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
[No Abstract] [Full Text] [Related]
15. Adjuvant interferon-alpha improves skin cancer survival.
Kerr C
Lancet Oncol; 2002 May; 3(5):262. PubMed ID: 12067791
[No Abstract] [Full Text] [Related]
16. Adjuvant therapy for patients with high-risk malignant melanoma.
McClay EF
Semin Oncol; 2002 Aug; 29(4):389-99. PubMed ID: 12170442
[TBL] [Abstract][Full Text] [Related]
17. Melanoma vaccines: possible progress after years of frustration?
Schmidt C
J Natl Cancer Inst; 2009 Feb; 101(3):140-1. PubMed ID: 19176461
[No Abstract] [Full Text] [Related]
18. The use of interferon alfa as adjuvant therapy for advanced cutaneous melanoma: the need for more evidence.
Kimyai-Asadi A; Usman A
J Am Acad Dermatol; 2000 Oct; 43(4):708-11. PubMed ID: 11004636
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
Schuchter LM
J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612
[No Abstract] [Full Text] [Related]
20. [Adjuvant interferon therapy in malignant melanoma].
Mohr P
J Dtsch Dermatol Ges; 2007 Jun; 5(6):543-5. PubMed ID: 17537052
[No Abstract] [Full Text] [Related]
[Next] [New Search]
